Company / Operating Income
AYTU BIOPHARMA, INC Operating Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$7.8M
FY2025
5-year range
-$109.9M / -$1.6M
FY2021-FY2025
Trend
-392.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -392% YoY in FY2025, a notable deviation from the 9-year average annual change of -74%.
Based on SEC 10-K filings.
-$8M in FY2025.
Improved from -$17M to -$8M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 392.0% year-over-year.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.8M | -392.0% |
| FY2024 | -$1.6M | +90.7% |
| FY2023 | -$17.1M | +84.5% |
| FY2022 | -$109.9M | -86.7% |
| FY2021 | -$58.9M | -178.6% |
| FY2020 | -$21.1M | -7.3% |
| FY2018 | -$19.7M | +2.1% |
| FY2017 | -$20.1M | +7.3% |
| FY2016 | -$21.7M | -184.4% |
| FY2015 | -$7.6M | -1304.9% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026